
Share on:
The seven largest public orthopedic companies spent $2.3+ billion on R&D in 2019 and 2020, an expense that was about 7% of their combined sales in 2019 and 8% in 2020, according to our estimates. Click the infographic to see R&D investments by dollars and percent of sales for DePuy Synthes, Stryker, Zimmer Biomet and more.
RELATED ARTICLES
The Orthopedic Additive Manufacturing Evolution You’ve Been Waiting For
Oct 06 2025 , Orchid Orthopedic Solutions
Carpenter Technology’s Proposed Cobalt-free Alternative to CoCrMo Alloys for Articulating Orthopedic Implants
Oct 02 2025 , Carpenter Technology